A randomized multicenter double-blind clinical trial to evaluate the efficacy and safety of 10mg alfuzosin in the treatment of chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) in recently-diagnosed and/or newly-symptomatic alpha-blocker naive patients
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2010
At a glance
- Drugs Alfuzosin (Primary)
- Indications Prostatitis
- Focus Therapeutic Use
- 18 Dec 2008 Results have been published in the New England Journal of Medicine.
- 12 Mar 2008 Status changed from in progress to completed. Updated from ClinicalTrials.gov.
- 11 Oct 2007 Status changed from recruiting to in progress.